Baird Financial Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $83.1M | Sell |
1,062,587
-2,311
| -0.2% | -$186K | 0.11% | 126 |
|
|
2026
Q1 | $92.3M | Sell |
1,064,898
-28,277
| -3% | -$2.71M | 0.14% | 105 |
|
|
2025
Q4 | $105M | Buy |
1,093,175
+12,356
| +1% | +$1.2M | 0.16% | 94 |
|
|
2025
Q3 | $103M | Sell |
1,080,819
-7,037
| -0.6% | -$647K | 0.17% | 99 |
|
|
2025
Q2 | $94.8M | Buy |
1,087,856
+2,458
| +0.2% | +$208K | 0.17% | 104 |
|
|
2025
Q1 | $97.5M | Buy |
1,085,398
+107,768
| +11% | +$9.64M | 0.19% | 98 |
|
|
2024
Q4 | $78.1M | Buy |
977,630
+56,034
| +6% | +$4.85M | 0.15% | 118 |
|
|
2024
Q3 | $83M | Sell |
921,596
-119,915
| -12% | -$10.1M | 0.16% | 121 |
|
|
2024
Q2 | $82M | Buy |
1,041,511
+30,603
| +3% | +$2.51M | 0.17% | 120 |
|
|
2024
Q1 | $88.1M | Buy |
1,010,908
+146,872
| +17% | +$12.5M | 0.18% | 124 |
|
|
2023
Q4 | $71.2M | Buy |
864,036
+34,653
| +4% | +$2.64M | 0.16% | 154 |
|
|
2023
Q3 | $65M | Sell |
829,383
-48,851
| -6% | -$4.09M | 0.18% | 131 |
|
|
2023
Q2 | $77.4M | Buy |
878,234
+25,026
| +3% | +$2.15M | 0.2% | 118 |
|
|
2023
Q1 | $68.8M | Buy |
853,208
+357,083
| +72% | +$29.1M | 0.17% | 141 |
|
|
2022
Q4 | $38.6M | Sell |
496,125
-292,984
| -37% | -$23.7M | 0.1% | 204 |
|
|
2022
Q3 | $63.7M | Buy |
789,109
+9,068
| +1% | +$815K | 0.19% | 132 |
|
|
2022
Q2 | $70M | Sell |
780,041
-30,577
| -4% | -$3.1M | 0.19% | 116 |
|
|
2022
Q1 | $89.9M | Buy |
810,618
+36,436
| +5% | +$3.85M | 0.22% | 99 |
|
|
2021
Q4 | $80.1M | Sell |
774,182
-49,387
| -6% | -$5.72M | 0.19% | 133 |
|
|
2021
Q3 | $103M | Buy |
823,569
+26,396
| +3% | +$3.42M | 0.26% | 89 |
|
|
2021
Q2 | $99M | Sell |
797,173
-22,403
| -3% | -$2.81M | 0.26% | 86 |
|
|
2021
Q1 | $96.8M | Sell |
819,576
-23,773
| -3% | -$2.79M | 0.27% | 81 |
|
|
2020
Q4 | $98.8M | Buy |
843,349
+26,555
| +3% | +$2.92M | 0.3% | 76 |
|
|
2020
Q3 | $84.9M | Buy |
816,794
+13,387
| +2% | +$1.34M | 0.29% | 76 |
|
|
2020
Q2 | $73.7M | Buy |
803,407
+367,416
| +84% | +$35.2M | 0.28% | 83 |
|
|
2020
Q1 | $39.3M | Buy |
435,991
+35,352
| +9% | +$3.76M | 0.18% | 144 |
|
|
2019
Q4 | $45.5M | Buy |
400,639
+20,863
| +5% | +$2.29M | 0.16% | 154 |
|
|
2019
Q3 | $41.3M | Buy |
379,776
+56,658
| +18% | +$5.91M | 0.16% | 157 |
|
|
2019
Q2 | $31.5M | Buy |
323,118
+67,721
| +27% | +$6.18M | 0.12% | 192 |
|
|
2019
Q1 | $23.3M | Buy |
255,397
+3,338
| +1% | +$299K | 0.14% | 199 |
|
|
2018
Q4 | $22.9M | Buy |
252,059
+25,673
| +11% | +$2.4M | 0.16% | 171 |
|
|
2018
Q3 | $22.5M | Buy |
226,386
+7,307
| +3% | +$676K | 0.14% | 182 |
|
|
2018
Q2 | $18.8M | Sell |
219,079
-7,131
| -3% | -$596K | 0.13% | 196 |
|
|
2018
Q1 | $18.1M | Buy |
226,210
+33,179
| +17% | +$2.74M | 0.13% | 201 |
|
|
2017
Q4 | $15.6M | Buy |
193,031
+80,880
| +72% | +$6.48M | 0.11% | 207 |
|
|
2017
Q3 | $8.72M | Buy |
112,151
+3,999
| +4% | +$332K | 0.07% | 293 |
|
|
2017
Q2 | $9.6M | Buy |
108,152
+1,185
| +1% | +$99.9K | 0.08% | 266 |
|
|
2017
Q1 | $8.62M | Buy |
106,967
+6,632
| +7% | +$518K | 0.07% | 277 |
|
|
2016
Q4 | $7.15M | Sell |
100,335
-56,413
| -36% | -$4.43M | 0.06% | 302 |
|
|
2016
Q3 | $13.5M | Buy |
156,748
+1,188
| +0.8% | +$104K | 0.12% | 183 |
|
|
2016
Q2 | $13.5M | Buy |
155,560
+26,707
| +21% | +$2.16M | 0.12% | 184 |
|
|
2016
Q1 | $9.66M | Buy |
128,853
+24,218
| +23% | +$1.82M | 0.09% | 224 |
|
|
2015
Q4 | $8.05M | Buy |
104,635
+160
| +0.2% | +$12K | 0.08% | 250 |
|
|
2015
Q3 | $6.99M | Buy |
104,475
+3,466
| +3% | +$255K | 0.07% | 266 |
|
|
2015
Q2 | $7.49M | Buy |
+101,009
| New | +$7.72M | 0.07% | 258 |
|
Other funds holding MDT
Baird Financial Group's MDT Position: Q2 2026 in Review
Baird Financial Group reduced its Medtronic (MDT) stake by 0.22% in Q2 2026, selling an estimated $186K and leaving 1,062,587 shares worth $83.1M. The position accounts for 0.11% of the portfolio, ranked #126.
Baird Financial Group first reported a position in MDT in Q2 2015 and has held it in 45 quarters since. The position peaked at $105M in Q4 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Baird Financial Group held 1,062,587 shares of Medtronic worth $83.1M as of Q2 2026.
- Baird Financial Group sold 2,311 Medtronic shares in Q2 2026, an estimated $186K.
- Medtronic made up 0.11% of Baird Financial Group's portfolio in Q2 2026, its #126 holding.
- Baird Financial Group first reported a position in Medtronic in Q2 2015 and has held it in 45 quarters since.
- Baird Financial Group's Medtronic position peaked at $105M in Q4 2025.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Baird Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.